miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

miR-200/ZEB axis regulates sensitivity to nintedanib in non-small cell lung cancer cells

Nintedanib (BIBF1120) is a multi-targeted angiokinase inhibitor and has been evaluated in idiopathic pulmonary fibrosis and advanced non-small cell lung cancer (NSCLC) patients in clinical studies. In the present study, we evaluated the antitumor effects of nintedanib in 16 NSCLC cell lines and trie...

Full description

Bibliographic Details
Main Authors: NISHIJIMA, NOBUHIKO, SEIKE, MASAHIRO, SOENO, CHIE, CHIBA, MIKA, MIYANAGA, AKIHIKO, NORO, RINTARO, SUGANO, TEPPEI, MATSUMOTO, MASARU, KUBOTA, KAORU, GEMMA, AKIHIKO
Format: Online
Language:English
Published: D.A. Spandidos 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750530/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750530/

Similar Items